Cassava Sciences (SAVA)
(Delayed Data from NSDQ)
$27.42 USD
-2.01 (-6.83%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $28.01 +0.59 (2.15%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Cassava Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -97.22 | -76.25 | -32.39 | -6.33 | -4.63 |
Depreciation/Amortization & Depletion | 1.53 | 1.30 | 0.53 | 0.02 | 0.06 |
Net Change from Assets/Liabilities | 9.08 | -4.64 | -0.10 | 0.29 | 0.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.59 | 2.07 | 1.76 | 0.64 | 1.30 |
Net Cash From Operating Activities | -82.03 | -77.51 | -30.20 | -5.38 | -2.51 |
Property & Equipment | -0.41 | -2.71 | -22.21 | 0.36 | -0.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.41 | -2.71 | -22.21 | 0.36 | -0.02 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.56 | 47.80 | 192.34 | 75.45 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 5.81 |
Net Cash from Financing Activities | 2.56 | 47.80 | 192.34 | 75.45 | 5.81 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -79.88 | -32.42 | 139.93 | 70.43 | 3.27 |
Cash at Beginning of Period | 201.02 | 233.44 | 93.51 | 23.08 | 19.81 |
Cash at End of Period | 121.14 | 201.02 | 233.44 | 93.51 | 23.08 |
Diluted Net EPS | -2.32 | -1.90 | -0.82 | -0.24 | -0.27 |
Fiscal Year End for Cassava Sciences, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 31.20 | 25.04 | -97.22 | -76.30 | -50.65 |
Depreciation/Amortization & Depletion | 0.61 | 0.31 | 1.53 | 1.17 | 0.78 |
Net Change from Assets/Liabilities | 34.07 | -3.78 | 9.08 | 12.96 | 15.18 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -103.24 | -40.71 | 4.59 | 2.46 | 1.51 |
Net Cash From Operating Activities | -37.37 | -19.13 | -82.03 | -59.71 | -33.18 |
Property & Equipment | -0.03 | 0.00 | -0.41 | -0.37 | -0.35 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.03 | 0.00 | -0.41 | -0.37 | -0.35 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 123.55 | 22.16 | 2.56 | 1.42 | 0.95 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 123.55 | 22.16 | 2.56 | 1.42 | 0.95 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 86.16 | 3.03 | -79.88 | -58.67 | -32.58 |
Cash at Beginning of Period | 121.14 | 121.14 | 201.02 | 201.02 | 201.02 |
Cash at End of Period | 207.29 | 124.17 | 121.14 | 142.35 | 168.44 |
Diluted Net EPS | 0.13 | -0.43 | -0.50 | -0.61 | -0.63 |